|
| 37255050 | Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System. | Laryngoscope | 2024 |
| 37955563 | Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence. | Clin Cancer Res | 2024 |
| 37658978 | Ablation techniques or active surveillance compared to surgical resection in patients with low-risk papillary thyroid cancer: a systematic review and meta-analysis. | Endocrine | 2024 |
| 37971722 | Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. | JAMA Oncol | 2024 |
| 36321223 | Hartmann's Reversal is More Complex Than Elective Left Colectomy. | Am Surg | 2023 |
| 37552307 | Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma. | J Cancer Res Clin Oncol | 2023 |
| 37655661 | Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression. | J Clin Invest | 2023 |
| 37940770 | Incidence rate and histology of appendiceal neoplasms in complicated versus uncomplicated appendicitis: A meta-analysis and systematic review. | Langenbecks Arch Surg | 2023 |
| 37819537 | Novel antibiotic irrigation device versus standard O-ring wound retractor in the prevention of surgical site infection following colorectal resection. | Int J Colorectal Dis | 2023 |
| 35580246 | Bilateral Gluteal Fasciocutaneous Advancement Flaps With and Without Tie-Over Sutures in Treatment of Chronic Pilonidal Disease: A Prospective Case Series. | Am Surg | 2023 |
| 37182801 | A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer. | Ann Oncol | 2023 |
| 37310528 | Robotic right versus left colectomy for colorectal neoplasia: a systemic review and meta-analysis. | J Robot Surg | 2023 |
| 37339797 | Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion. | J Immunother Cancer | 2023 |
| 37205330 | Linked CD4 <sup>+</sup> /CD8 <sup>+</sup> T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression. | bioRxiv | 2023 |
| 37171962 | Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway. | Cell Rep | 2023 |
| 37464051 | Author Correction: Neoantigen-specific stem cell memory-like CD4<sup>+</sup> T cells mediate CD8<sup>+</sup> T cell-dependent immunotherapy of MHC class II-negative solid tumors. | Nat Immunol | 2023 |
| 37000164 | Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial. | Clin Cancer Res | 2023 |
| 36965195 | Expert Consensus Statement: Management of Dysphagia in Head and Neck Cancer Patients. | Otolaryngol Head Neck Surg | 2023 |
| 37470901 | Does coffee affect bowel recovery following minimally invasive colorectal operations? A three-armed randomized controlled trial. | Int J Colorectal Dis | 2023 |
| 36512410 | Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells. | JCI Insight | 2023 |
| 34340861 | Predictors of lymph node metastases in patients with malignant adenomatous polyps of the colon. | Am J Surg | 2022 |
| 35790753 | Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. | Nat Commun | 2022 |
| 36279618 | A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma. | Oral Oncol | 2022 |
| 36272826 | Hartmann's reversal is associated with worse outcomes compared to elective left colectomy: A NSQIP analysis of 36,794 cases. | Am J Surg | 2022 |
| 36194164 | A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck. | Clin Cancer Res | 2022 |
| 36159902 | Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis. | World J Otorhinolaryngol Head Neck Surg | 2022 |
| 36395141 | Somatic 9p24.1 alterations in HPV<sup>-</sup> head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity. | Proc Natl Acad Sci U S A | 2022 |
| 35879302 | Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. | Nat Commun | 2022 |
| 35123577 | Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report. | J Otolaryngol Head Neck Surg | 2022 |
| 35277768 | Robotic colorectal procedures: does operative start time impact short-term outcome? | Surg Endosc | 2022 |
| 35172587 | Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase IIIÂ study design. | Future Oncol | 2022 |
| 34965944 | Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial. | Clin Cancer Res | 2022 |
| 34898046 | Analysis of CDK12 alterations in a pan-cancer database. | Cancer Med | 2022 |
| 34862248 | Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. | Clin Cancer Res | 2022 |
| 34581955 | Minimally invasive right versus left colectomy for cancer: does robotic surgery mitigate differences in short-term outcomes? | J Robot Surg | 2022 |
| 34848533 | Inevitable Progress-Relying on the Immune System, Not Chance. | Clin Cancer Res | 2022 |
| 32407532 | Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. | J Natl Cancer Inst | 2021 |
| 33794205 | Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. | Lancet Oncol | 2021 |
| 33888713 | Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. | Nat Commun | 2021 |
| 35008197 | Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers. | Cancers (Basel) | 2021 |
| 34621678 | Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities. | Front Oncol | 2021 |
| 34504503 | The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community. | Front Immunol | 2021 |
| 33989559 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. | Lancet Oncol | 2021 |
| 34197753 | Patient selection for immunotherapy in head and neck cancer - Authors' reply. | Lancet Oncol | 2021 |
| 34230025 | Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients. | Clin Cancer Res | 2021 |
| 34255745 | Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. | JCI Insight | 2021 |
| 33051762 | Use of right colon vaginoplasty in gender affirming surgery: proposed advantages, review of technique, and outcomes. | Surg Endosc | 2021 |
| 33239737 | Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer. | Mod Pathol | 2021 |
| 33122346 | The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification. | Clin Cancer Res | 2021 |
| 32862977 | Adenosquamous carcinoma: An aggressive histologic sub-type of colon cancer with poor prognosis. | Am J Surg | 2021 |